Back

Assessment of left ventricular global longitudinal strain (LVGLS) before and after MiitraClip therapy in patients with heart failure and secondary mitral regurgitation

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Mitral and tricuspid interventions Mitral Valve Intervention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Miss Mishal Khan

Islamabad (Pakistan)

6 More presentations in this session

Presentation thumbnail
Tri-score a powerful tool for comprehensive risk stratification in tricuspid regurgitation management
Doctor S. Gharehdaghi (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Exponential growth of tricuspid interventions in Germany
Mr J. Voran (Kiel, DE)
Abstract Slides Video
Presentation thumbnail
Right ventricular-pulmonary artery coupling as an indicator of clinical outcomes in patients undergoing transcatheter tricuspid annuloplasty
Doctor J. Salinas-Casanova (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Mitral annulus geometry after edge-to-edge repair: findings from the VEGA international Registry
Doctor M. Mennuni (Novara, IT)
Abstract Slides Video
Presentation thumbnail
Outcomes of transcatheter edge-to-edge repair in patients with previous transcatheter aortic valve replacement: a systematic review and meta-analysis
Doctor A. Haidarah (Chengdu, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Mitral and tricuspid interventions

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Transcatheter edge-to-edge mitral valve repair: a meta-analysis of hospitalization outcomes in heart failure and secondary mitral regurgitation
thumbnail
Congress Presentation
TEER plus medical therapy vs medical therapy alone for symptomatic moderate-to-severe functional mitral regurgitation: a comprehensive, up-to-date meta-analysis of randomized trials
thumbnail
Congress Presentation
Percutaneous mitral valve repair should have a Class I recommendation for the management of significant secondary mitral regurgitation in heart failure: pro

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources